Importance of Detecting Multidrug Resistance Proteins in Acute Leukemia Prognosis and Therapy
| Autor: | Caroline Klein Maranho, Gabriela Schneider Rauber, Maria Cláudia Santos-Silva, Ana Carolina Rabello de Moraes |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Microbiology (medical)
Acute leukemia biology business.industry Biochemistry (medical) Clinical Biochemistry Public Health Environmental and Occupational Health ATP-binding cassette transporter Hematology Multiple drug resistance Medical Laboratory Technology Cell culture Cytoplasm Immunology Multidrug Resistance Proteins Cancer research ABCC1 biology.protein Immunology and Allergy Medicine Efflux business |
| Zdroj: | Journal of Clinical Laboratory Analysis. 27:62-71 |
| ISSN: | 0887-8013 |
| DOI: | 10.1002/jcla.21563 |
| Popis: | Multidrug resistance (MDR) is a multifactorial phenomenon and the role of these proteins in generating the MDR phenotype is controversial. With this in mind, this review compiled the current data on the role of ABCB1, ABCC1, and LRP proteins in the prognosis of hematologic neoplasms and their influence on the choice of therapy. Literature showed that the detection of these proteins, mainly ABCB1, is important in the AL prognosis. However, there is controversy regarding the methodology used for their detection. In summary, the expression and activity profiles of ABCB1, ABCC1, and LRP, proteins capable of promoting the efflux of a variety of chemotherapeutic agents from the cell cytoplasm represent one of the greatest causes of failure in AL treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|